Capricor Therapeutics | CAPR - Pre Tax Profit


Capricor Therapeutics reported $-30.17M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 11.69B 6.85B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Grifols EUR 257.85M 190.87M Dec/2024
Immunic USD -21.38M 8.2M Jun/2024
J&J USD 4.97B 2.53B Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Prothena USD -21.58M 15.33M Dec/2025
PTC Therapeutics USD -139.08M 116.01M Dec/2025
Sarepta Therapeutics USD -407.67M 213.63M Dec/2025